Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical, Inc.

Avanos Medical is a medical device company dedicated to challenging the status quo in healthcare. Its solutions focus on pain management, respiratory care, and digestive care.

msh id	COM:AVANOS
symbol	AVNS
name	Avanos Medical, Inc.
homepage url	https://avanos.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	3.77K
crunchbase url	-
linkedin url	-
founders	-

market cap	890.08M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-0.17
growth cost of revenue	-0.21
growth depreciation and amortization	-0.06
growth ebitda	-0.2
growth ebitda ratio	-0.02
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-0.15
growth gross profit ratio	0.04

COM:AVANOS

Avanos Medical

Last Close

17.87

21/11 20:19

Market Cap

890.08M

Beta: -

Volume Today

161.53K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	620.9M
cost of revenue	620.9M
depreciation and amortization	46.1M
ebitda	98.5M
ebitda ratio	0.15
eps	-1.33
eps diluted	-1.33
operating expenses	330.3M
operating income	52.4M
operating income ratio	0.08

accounts receivables	39M
capital expenditure	-17.8M
cash at beginning of period	127.7M
cash at end of period	87.7M
inventory	163.2M
working capital ttm	353.9M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-